ESMC Stock Overview
Engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals for ophthalmic applications in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Escalon Medical Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.15 |
| 52 Week High | US$0.30 |
| 52 Week Low | US$0.11 |
| Beta | -0.24 |
| 11 Month Change | 29.87% |
| 3 Month Change | 6.46% |
| 1 Year Change | -26.83% |
| 33 Year Change | 15.38% |
| 5 Year Change | 0% |
| Change since IPO | -99.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| ESMC | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -6.3% | -0.4% | -1.0% |
| 1Y | -26.8% | 20.3% | 30.3% |
Return vs Industry: ESMC underperformed the US Medical Equipment industry which returned 20.9% over the past year.
Return vs Market: ESMC underperformed the US Market which returned 30.4% over the past year.
Price Volatility
| ESMC volatility | |
|---|---|
| ESMC Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine ESMC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 40 | Rich DePiano | www.escalonmedical.com |
Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals for ophthalmic applications in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea. The company also provides Ispan Intraocular Gases, such as C3F8 and SF6 that are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and AXIS Image management system for managing ophthalmic diagnostic images through the web browser from various devices.
Escalon Medical Corp. Fundamentals Summary
| ESMC fundamental statistics | |
|---|---|
| Market cap | US$1.19m |
| Earnings (TTM) | -US$187.92k |
| Revenue (TTM) | US$11.82m |
0.1x
P/S Ratio-5.9x
P/E RatioIs ESMC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ESMC income statement (TTM) | |
|---|---|
| Revenue | US$11.82m |
| Cost of Revenue | US$6.75m |
| Gross Profit | US$5.06m |
| Other Expenses | US$5.25m |
| Earnings | -US$187.92k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.025 |
| Gross Margin | 42.84% |
| Net Profit Margin | -1.59% |
| Debt/Equity Ratio | 16.7% |
How did ESMC perform over the long term?
See historical performance and comparison